Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000904454-26-000123·Arcellx, Inc.
Schedule 13D ownership disclosure
Arcellx Inc
Common Stock, par value $0.001 · CUSIP: 03940C100
Event date: 2026-02-23
- Filing-level shares
- 6,720,803.00
- Percent of class
- 11.5%
- Gilead Sciences, Inc.Reported CIK 0000882095
Shares: 6,720,803.00 · Class: 11.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-26-000123
- Form type
- SCHEDULE 13D
- Filer
- Arcellx, Inc.
- CIK
- CIK 1786205
- Filed
- Feb 23, 2026
- Reporting period
- Feb 23, 2026
- Description
- Schedule 13D beneficial ownership